Skip to main content
P

PCL. Inc — Investor Relations & Filings

Ticker · 241820 ISIN · KR7241820000 KO Manufacturing
Open in API
Filings indexed 681 across all filing types
Latest filing 2025-04-04 Regulatory Filings
Country KR South Korea
Listing KO 241820

About PCL. Inc

http://www.pclchip.com/

PCL, Inc. is a company that develops and manufactures in-vitro diagnostic (IVD) medical devices, specializing in multiplex immunodiagnosis. The company's core offering is based on its proprietary SG Cap™ Technology, a platform for creating advanced diagnostic solutions. Its product portfolio includes automated multi-immune diagnostic systems, blood testing kits, cancer screening tests, and rapid antigen kits. PCL also provides platform services, reagents, and related equipment such as desktop arrayers to the medical and diagnostic fields.

Recent filings

Filing Released Lang Actions
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the amendment of a previously disclosed contract, specifically updating the counterparty and supply region after a period of confidentiality (유보). Since this is a specific regulatory disclosure regarding a material contract update and does not fit into the other specialized categories like M&A or Share Issues, it is classified as a Regulatory Filing (RNS).
2025-04-04 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It is a correction filing (정정신고) for a previously disclosed contract from 2020, updating details such as the counterparty name and supply region after a confidentiality period expired. Since this is a specific regulatory disclosure regarding a commercial contract and does not fit into categories like financial reports or shareholder meetings, it falls under the general regulatory filing category.
2025-04-04 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korean stock exchange (KIND) regarding a 'Correction Report' (정정신고) for a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details the correction of previously withheld information regarding a contract with a counterparty. Since this is a specific regulatory disclosure regarding a material contract update that does not fit into categories like financial reports or shareholder meetings, it falls under the general regulatory filing category.
2025-04-04 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It is a correction filing (정정신고) for a previously disclosed contract, providing updated details on the counterparty and supply region after a confidentiality period expired. Since this is a specific regulatory disclosure of a business contract and does not fit into categories like earnings, dividends, or board changes, it is classified as a general regulatory filing.
2025-04-04 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Correction Report' (정정신고) for a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the amendment of a previously disclosed contract, specifically updating the counterparty and supply region after a confidentiality period expired. Since this is a specific regulatory disclosure regarding a commercial contract update and does not fit into categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2025-04-04 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It is a correction filing (정정신고) for a previously disclosed contract from 2020, updating details such as the counterparty and supply region after a confidentiality period expired. Since this is a specific regulatory disclosure regarding a commercial contract and does not fit into categories like financial reports, dividends, or management changes, it falls under the general regulatory filing category.
2025-04-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.